Tizanidine Tablet
Product Images NDC 80425-0436

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 80425-0436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine 2mg #30 (Tizanidine 2mg 80425 0436 01)

Label for Tizanidine 2 mg oral tablets by Advanced Rx of Tennessee, LLC. The label indicates a quantity of 30 tablets, includes NDC numbers 80425-0436-01 and 72578-0096-10, and lists an expiration date of 9/30/2025. Storage instructions specify 20°-25°C (68°-77°F), with a caution against transferring the drug to other containers.*

FDA Label Image

Tizanidine 2mg #60 (Tizanidine 2mg 80425 0436 02)

Tizanidine 2 mg tablet packaging label by Advanced Rx of Tennessee, LLC, Nashville, TN. The label includes NDC numbers, lot number, expiration date of 9/30/2025, and a barcode. It also notes a comparison to Zanaflex and storage instructions between 20-25°C (68-77°F). Marked Rx only.*

FDA Label Image

Tizanidine 2mg #90 (Tizanidine 2mg 80425 0436 03)

Tizanidine 2 mg tablet packaging label by Advanced Rx of Tennessee, LLC. The label includes storage instructions (20°-25°C), caution against drug transfer, and compares to Zanaflex. It lists NDC numbers and a lot expiration date of 9/30/2025. The label states Rx Only and includes partial manufacturer information, Viona Pharmaceu.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 01)

Chemical structure of Tizanidine hydrochloride, showing chlorine and sulfur atoms within a fused ring system and attached heterocyclic moieties.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 02)

A line graph showing plasma Tizanidine concentration (ng/mL) over 24 hours post-dosing. It compares four conditions: 2 x 4 mg Tizanidine tablets with food, without food; and 2 x 4 mg Tizanidine capsules with food, without food. The graph displays concentration peaks around 1-2 hours and a decline towards zero by 24 hours.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 03)

A line graph depicting improvement in Ashworth Score over 6 hours post-dose for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The vertical axis shows improvement score, ranging from -5 to 1, and the horizontal axis shows hours post-dose from 0 to 6. The 16 mg dose shows the greatest improvement peak around 2 hours followed by gradual decline.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 04)

A line graph depicting improvement in Ashworth Score over time with Tizanidine (mean dose 28.8 mg) compared to placebo. The x-axis shows three time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). The y-axis ranges from -6 to 2, indicating improvement scores, with lower values representing greater improvement. Tizanidine shows consistent improvement with error bars, whereas placebo shows little to no improvement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.